Basel, 9 December 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the CE Mark for its cobas® BV/CV (Bacterial Vaginosis/Candida Vaginitis) assay to accurately identify specific bacteria and ...
“We are delighted to introduce David Hale as the new CEO of Ascom,” says Dr. Valentin Chapero, Chairman of the Board of Directors of Ascom Holding AG. “His leadership skills, international perspective ...
Gazyva/Gazyvaro is approved for adults with lupus nephritis in the United States and European Union and in over 100 countries for various types of haematological cancers.
The opening ceremony of the 2025 Greater Bay Area Science Forum was held in Guangzhou on December 7. Under the theme "Industry Research Integration Drives Smart Innovation in the GBA", the forum is ...
VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) (“ Monument ” or the “ Company ”) is pleased to announce the results from its Annual ...
Basel, 8 December 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new data highlighting the potential of Lunsumio® (mosunetuzumab) in earlier treatment lines for people living with different ...
“OtterSec brings strong expertise in deep vulnerability research and complex exploits. Combining that with Asymmetric Research’s holistic approach gives companies one aligned group that can cover the ...
The ECCCSAs are Europe’s largest and most prestigious awards program for customer contact and customer service organizations, celebrating innovation, excellence, and impact across the industry. TTEC ...
BIRMINGHAM, Ala., Dec. 08, 2025 (GLOBE NEWSWIRE) -- We are proud to announce that for the seventh consecutive year, Harbert Management Corporation (“HMC”) has been voted one of the Best Places to Work ...
CRANSTON, R.I., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Nelipak® Corporation (“Nelipak”), a leading global provider of healthcare packaging solutions, announced today that it has completed the acquisition ...
“A Strategic Lithium Reserve is the simplest, fairest, and fastest policy tool available,” said Howard Klein, Founder of RK Equity. “It doesn’t pick technologies or subsidize risky projects. It ...
Overall survival was twice as long for people treated with Columvi in combination with GemOx versus MabThera/Rituxan plus GemOx1; This Columvi combination is available off-the-she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback